No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
AMLX Amylyx Pharmaceuticals
- 4.050
- +0.090+2.27%
Close Dec 20 16:00 ET
- 4.060
- +0.010+0.25%
Post 20:01 ET
277.62MMarket Cap-1.06P/E (TTM)
4.180High3.960Low550.92KVolume3.980Open3.960Pre Close2.24MTurnover1.30%Turnover Ratio5.79P/E (Static)68.55MShares19.94952wk High1.42P/B171.69MFloat Cap1.57552wk Low--Dividend TTM42.39MShs Float41.930Historical High--Div YieldTTM5.56%Amplitude1.575Historical Low4.065Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Investors Don't See Light At End Of Amylyx Pharmaceuticals, Inc.'s (NASDAQ:AMLX) Tunnel And Push Stock Down 26%
Selling Amylyx Pharmaceuticals Shares at a Lower Price Than Current Market Value May Have Been a Costly Mistake for Insiders
BofA Securities Maintains Amylyx Pharmaceuticals(AMLX.US) With Buy Rating, Announces Target Price $10
H.C. Wainwright Maintains Amylyx Pharmaceuticals(AMLX.US) With Buy Rating, Maintains Target Price $12
HC Wainwright & Co. Reiterates Buy on Amylyx Pharma, Maintains $12 Price Target
Express News | Amylyx Pharmaceuticals Shares up 1.7% on Late-Stage Trial Update for Low-Blood Sugar Drug
Heat List
US
Overall
Symbol
Price
% Chg
No Data